On Wednesday morning, Mark Zuckerberg, Sundar Pichai, and Jack Dorsey will appear remotely at a hearing titled “Does Section 230’s Sweeping Immunity Enable Big Tech Bad Behavior?” The law, part of the Communications Decency Act of 1996, gives interactive computer services broad legal immunity for content posted by users.
Senator Josh Hawley, who wants to strip Section 230 protections from platforms if they moderate misinformation in political speech, cited Thomas’ memo and asked Barrett her views about it.Pai gave us a hint of his thinking: “Social media companies have a First Amendment right to free speech,” he wrote.
Throughout the Covid-19 pandemic , scientists have been saying that if the novel coronavirus, SARS-CoV-2, sticks around long enough, people are likely to catch it more than once.On Monday, researchers at Hong Kong University presented the first confirmation that this can, in fact, happen with SARS-CoV-2.
“This action follows new analyses of data that raised questions about potential human health risks from chronic dietary exposure—findings that warrant further study,” FDA commissioner Stephen Hahn and Susan Mayne, director of the FDA’s Center for Food Safety and Applied Nutrition, wrote in a statement.
At this stage, the study can’t tell us whether people who have the vaccine are protected against contracting Covid-19, but it does tell us that the vaccine is safe to use, and that it provokes an immune response .So We Haven’t Actually Solved the Vaccine Problem Yet. Not yet, no.
This means that the herd immunity threshold will also be higher than 60 percent in some places and lower in others.“I think the range of R0 consistent with data for Covid-19 is larger than most people give credit to,” said Marc Lipsitch of Harvard University, who has been advising health officials in Massachusetts and abroad.
Along with a wide mix of research teams in laboratories across the world, Glanville is pursuing antibody treatments as a complementary tool to fight Covid-19.Right now, the blood plasma from recovered coronavirus patients can be transfused into people who are currently fighting the disease, as a way to introduce effective antibodies into their systems.
But when it comes to SARS-CoV-2, “because this is such a new infection, we’re not sure how long those antibodies hang around for,” says Dr. Seema Yasmin, director of the Stanford Health Communication Initiative.
While the international science community condemned He’s experiment for a host of ethics violations, using Crispr and other gene-editing tools to recreate the protective effects of the CCR5 mutation might lead to treatments so widely available that we don’t have to refer to patients as the London this or the Berlin that any more.